Intradetrusor botulinum toxin type A in refractory overactive bladder: A potential future treatment.
作者信息
Mahajan Rajiv, Singh Navyug Raj
机构信息
Department of Pharmacology, Adesh Institute of Medical Sciences and Research, Bathinda - 151101, India.
出版信息
Int J Appl Basic Med Res. 2011 Jul;1(2):67-70. doi: 10.4103/2229-516X.91144.
Abstract
摘要
相似文献
1
Intradetrusor botulinum toxin type A in refractory overactive bladder: A potential future treatment.肉毒杆菌毒素A膀胱内注射治疗难治性膀胱过度活动症：一种潜在的未来治疗方法。
Int J Appl Basic Med Res. 2011 Jul;1(2):67-70. doi: 10.4103/2229-516X.91144.
2
[Seniority of neurobladder and effectiveness of a first intradetrusor injection of botulinum toxin].[神经源性膀胱的病程及首次膀胱逼尿肌内注射肉毒杆菌毒素的疗效]
Prog Urol. 2015 Sep;25(11):642-8. doi: 10.1016/j.purol.2015.05.008. Epub 2015 Jun 17.
3
[Botulinum toxin injection for refractory non-neurogenic overactive bladder. Systematic review].[肉毒杆菌毒素注射治疗难治性非神经源性膀胱过度活动症。系统评价]
Rev Med Brux. 2015 Jan-Feb;36(1):29-37.
4
Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial.膀胱内注射脂质体包裹的肉毒毒素 A 可改善膀胱过度活动症症状：一项前瞻性、多中心、双盲、随机试验。
J Urol. 2014 Dec;192(6):1743-9. doi: 10.1016/j.juro.2014.07.008. Epub 2014 Jul 18.
5
6
Botulinum toxin injections for adults with overactive bladder syndrome.肉毒杆菌毒素注射治疗成人膀胱过度活动症
Cochrane Database Syst Rev. 2011 Dec 7(12):CD005493. doi: 10.1002/14651858.CD005493.pub3.
7
Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive Bladder.肉毒毒素化学去神经治疗逼尿肌过度活动症的过去、现在和未来。
J Urol. 2017 Apr;197(4):982-990. doi: 10.1016/j.juro.2016.11.092. Epub 2016 Nov 18.
8
[Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder].[肉毒杆菌毒素膀胱逼尿肌内注射治疗神经源性膀胱过度活动症的临床及尿动力学结果前瞻性研究]
Prog Urol. 2008 Jul;18(7):449-55. doi: 10.1016/j.purol.2008.03.014. Epub 2008 May 27.
9
Botulinum toxin and refractory non-neurogenic overactive detrusor.肉毒毒素与难治性非神经源性逼尿肌过度活动。
Ann Phys Rehabil Med. 2009 Nov;52(9):668-83. doi: 10.1016/j.rehab.2009.07.032. Epub 2009 Aug 13.
10
[Patient follow-up after botulinum toxin intradetrusor injection. Proposal for management in neurogenic patients].[肉毒杆菌毒素膀胱逼尿肌内注射后的患者随访。神经源性患者的管理建议]
Ann Readapt Med Phys. 2008 May;51(4):315-21. doi: 10.1016/j.annrmp.2008.03.003. Epub 2008 May 7.
本文引用的文献
1
Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder.A型肉毒毒素治疗帕金森病伴难治性膀胱过度活动症患者。
J Urol. 2011 Sep;186(3):960-4. doi: 10.1016/j.juro.2011.04.071. Epub 2011 Jul 24.
2
Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.A型肉毒毒素注射治疗神经原性逼尿肌过度活动和尿失禁的疗效：一项随机、双盲试验。
J Urol. 2011 Jun;185(6):2229-35. doi: 10.1016/j.juro.2011.02.004. Epub 2011 Apr 16.
3
Update on the pharmacologic management of overactive bladder: the present and the future.膀胱过度活动症药物治疗的最新进展：现状与未来。
Urol Nurs. 2010 Jan-Feb;30(1):29-38, 53. doi: 10.7257/1053-816x.2010.30.1.29.
4
Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.A型肉毒毒素-A（丽舒妥）：临床适应证和实践指南。
Aesthet Surg J. 2009 Nov;29(6 Suppl):S72-9. doi: 10.1016/j.asj.2009.09.016.
5
Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence.口服抗胆碱能药物难治性急迫性尿失禁的膀胱过度活动症治疗成功：已发表证据的综述。
BMC Urol. 2009 Nov 20;9:18. doi: 10.1186/1471-2490-9-18.
6
Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.难治性神经源性逼尿肌过度活动患者膀胱内注射A型肉毒杆菌毒素的六年随访：临床和尿动力学结果
Eur Urol. 2009 Mar;55(3):705-11. doi: 10.1016/j.eururo.2008.08.048. Epub 2008 Sep 2.
7
Muscarinic receptor antagonists for overactive bladder.用于治疗膀胱过度活动症的毒蕈碱受体拮抗剂。
BJU Int. 2007 Nov;100(5):987-1006. doi: 10.1111/j.1464-410X.2007.07205.x.
8
Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.对神经源性逼尿肌过度活动患者注射A型肉毒杆菌毒素可显著降低有症状的尿路感染的发生率。
Eur Urol. 2008 Mar;53(3):613-8. doi: 10.1016/j.eururo.2007.08.039. Epub 2007 Aug 28.
9
Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.A型肉毒杆菌毒素治疗特发性逼尿肌过度活动症的疗效：一项单中心、随机、双盲、安慰剂对照试验的结果
J Urol. 2007 Jun;177(6):2231-6. doi: 10.1016/j.juro.2007.01.130.
10
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.五个国家基于人群的尿失禁、膀胱过度活动症及其他下尿路症状调查：EPIC研究结果
Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5. doi: 10.1016/j.eururo.2006.09.019. Epub 2006 Oct 2.
Zotero 插件